Press "Enter" to skip to content

Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018

GSK retains No 1 position, as Novartis overtakes J&J to take 2nd place. Takeda jumps 10 places to 5th.

Original source: https://health.economictimes.indiatimes.com/news/pharma/only-a-handful-of-pharma-cos-are-developing-the-much-needed-medicines-for-the-poor-atmi-2018/66711514?utm_source=RSS&utm_medium=ETRSS

Also Read:   Biocon Biologics appoints M.B. Chinappa as CFO